Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Communication Strategies. Case Studies. Applied Knowledge.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Regulatory News | 09 August 2016 | By Zachary Brennan
Australia’s Therapeutic Goods Administration (TGA) on Tuesday announced upcoming changes to the way medicine labels on the island will look and be laid out in order to make more pertinent information about medicines easier to find.
The changes, which will be implemented over four years beginning 31 August 2016, will be made available in Australia’s Federal Register of Legislation from 17 August 2016, along with guidance on how to apply the new labeling orders.
The four-year transition period will allow drug sponsors time to adapt to the new requirements, and from 1 September 2020 all new medicine labels will need to meet the new requirements, TGA says.
Since labeling requirements for Australian drugs have not been amended since 2014, the update will further align the labels with international best practice, TGA says.
The main changes include:
“Prescription medicines will also have a designated space for a dispensing label,” TGA explains. “These labels are applied by the pharmacist and include important information like your name and dosage instructions. The defined space for a dispensing label space will help ensure that other information included on a carton or bottle is not covered.”
In terms of the regulations, the label requirements have been split into two new labeling orders:
TGA says the split was applied to better consider the different risk levels for prescription and non-prescription medicines and also to improve overall readability.
During the four-year transition period, pharmaceutical sponsors can choose to comply with the old labeling requirements under TGO 69 or the new labeling requirements under TGO 91/92 (whichever applies).
“Labels must fully comply with all requirements of either the old or the relevant new Order. A label cannot selectively comply with parts of multiple Orders,” TGA says.
After the transition period, all medicines must comply with either TGO 91 or TGO 92.
Australia's medicine labels are becoming clearer
Tags: Australia drug labels, drug label, drug labeling changes, dispensing label